Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
NEW YORK, Sept. 14 /PRNewswire-FirstCall/ -- Pfizer Inc said today that it has completed its acquisition of Vicuron Pharmaceuticals Inc...
KING OF PRUSSIA, Pa., Sept. 11 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (Nasdaq: MICU; Nuovo Mercato) announces that the waiting...
KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (Nasdaq: MICU; Nuovo Mercato: MICU) announced today it...
KING OF PRUSSIA, Penn., Aug. 15 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals (Nasdaq: MICU; Nuovo Mercato) announced that its stockholders...
KING OF PRUSSIA, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (NASDAQ:MICUNASDAQ:NuovoNASDAQ:Mercato) today reported...
Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Anti-Infectives Vicuron Products Anidulafungin and Dalbavancin...
Vicuron Pharmaceuticals Receives Issued Patent for Dalbavancin Dosing by U.S. Patent and Trademark Office KING OF PRUSSIA, Penn., June 2...
Vicuron Pharmaceuticals Files Amendment to Anidulafungin New Drug Application (NDA) for Treatment of Esophageal Candidiasis KING OF PRUSSIA, Pa...
Vicuron Pharmaceuticals to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference and the Pacific Growth Equities Annual...
Vicuron Pharmaceuticals to Present at the 2005 Needham Biotech Conference KING OF PRUSSIA, Pa., May 17 /PRNewswire-FirstCall/ -- Vicuron...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지